VAXIGRIP INFLUENZA VACCINE (0.5ML SYRINGE)

Manufacturer
SANOFI PASTEUR(FRANCE)

Registraction Number
MAL19880007ARZ

Content:

• Active Ingredient: Split influenza virus (inactivated) containing:
  • A/Victoria/4897/2022 (H1N1)pdm09-like strain: 15 micrograms of haemagglutinin
  • A/Thailand/8/2022 (H3N2)-like strain: 15 micrograms of haemagglutinin
  • B/Austria/1359417/2021-like strain: 15 micrograms of haemagglutinin
  • B/Phuket/3073/2013-like strain: 15 micrograms of haemagglutinin.

• Prevention of influenza: Recommended for active immunization of adults, including pregnant women, and children from 6 months of age.
• Passive protection: Protects infants from birth to less than 6 months of age when administered to pregnant women.

1. Dosage: One dose of 0.5 ml for adults and children from 6 months of age.
2. Children under 9 years: A second dose of 0.5 ml should be given after an interval of at least 4 weeks if they have not been previously vaccinated.
3. Administration: Injected intramuscularly (IM) or subcutaneously (SC). The preferred site for IM injection is the deltoid muscle for adults and the anterolateral aspect of the thigh for children under 36 months.
4. Storage: Store in a refrigerator at 2°C to 8°C. Shake gently before use.
5. Timing: Annual vaccination is recommended due to the variation of influenza virus strains.